Biggest News Aggregation in the World
📰 Bio News

Page 349 - Bio News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Bio. Real-time updates on events, politics, business and more.

Looking for investor for new biomass plant in Canada

Looking for investor for new biomass plant in Canada Price: 7000000.00 USD We are located in Ontario Canada, we are looking for investors in our Company ( baurenhof biomass ) We need $7. Milj usd dollars, we have property and land to build on central Ontario close to us border and any port !! we have the machines line up to make Briquettes for bio-mass , also contract is in place to turn 40.000 acres (200.000 ) ton of hemp straw into briquettes logs from 30 cm and also packing in 3 and 5 ...
Ontario Canada ஆஂடேரியொ கனடா

A journey through Chile's conflict with Mapuche rebel groups | Conflict News

Hector Llaitul, leader of the CAM The south-central region of Chile is breathtakingly beautiful. There are snow-capped volcanoes, lakes and rivers, and majestic Araucaria trees that are hundreds of years old. There are endless forests and wheat fields. And, until 150 years ago, it was all Indigenous Mapuche territory. The Mapuche call it Wallmapu, which means “men of the earth” in their language, Mapuzugun. The majority of the Mapuche live in Chile, but there are also some on the other side...
Camilo Catrillanca Francisco Huenchumilla Weichan Auka Mapu Camilo Sanchez Boroa Mapuche Hector Llaitul

Emergent gets $23 million additional order for vaccine production

By Reuters Staff 1 Min Read FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and sryinge are seen in front of displayed Johnson&Johnson logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photo (Reuters) - Emergent BioSolutions Inc said late on Sunday that a key U.S. agency has increased an order, related to the manufacturing of Johnson & Johnson’s COVID-19 vaccine, by $23 million. The amount will be used to purchase biologics equipment specific to...
Shailesh Kuber Juby Babu Baltimore Bayview Thomson Reuters Trust Principles Emergent Biosolutions Inc Astrazeneca Plc

WuXi Biologics says to acquire Pfizer's biologic drug plant in China

By Reuters Staff 2 Min Read BEIJING (Reuters) - Pfizer Inc will stop producing biosimilar products in China and sell a unit in the eastern city of Hangzhou to WuXi Biologics Inc, the U.S. drugmaker said on Wednesday. FILE PHOTO: Pfizer logo seen outside their building in Manhattan, New York City, New York, U.S., March 2, 2021. REUTERS/Carlo Allegri The pharmaceutical industry increasingly relies on costly biologic drugs, made from living organisms that are tougher and more expensive to make tha...
Roxanne Liu Kim Coghill Miyoung Kim Thomson Reuters Trust Principles Pfizer Inc University Of Oxford

About The Ric Edelman Show

  The Ric Edelman Show provides an entertaining and unique approach to financial advice you won’t find anywhere else. One of the most acclaimed financial advisors in the country, Ric covers the wide range of personal finance topics that are more important to you and your daily life: planning for college and retirement, handling your mortgage, maximizing your Social Security benefits, creating wills and trusts, participating in your workplace retirement plan, taxes, deciding if you need insur...
Ric Edelman Show Social Security The Truth About Money Ric Edelman ரிக் எடெல்மேன் காட்டு சமூக பாதுகாப்பு
Source: iheart.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

bluebird bio : Provides Updated Findings from Reported Case of Acute Myeloid Leukemia (AML) in LentiGlobin for Sickle Cell Disease (SCD) Gene Therapy Program

Message : Required fields Analyses demonstrate lentiviral vector BB305 unlikely to be the cause of AML in clinical study of LentiGlobin for SCD bluebird bio has initiated process with regulators to resume clinical studies Company to hold conference call and webcast today, March 10, 2021, 8:00 AM EST bluebird bio, Inc. (Nasdaq: BLUE) announced today that based on the analyses completed to date, it is very unlikely the Suspected Unexpected Serious Adverse Reaction (SUSAR) of acute myeloid leukemi...
United States United Kingdom Philip Gregory Pharmacovigilance Risk Assessment Committee European Commission Drug Administration

Sensex, Nifty pare gains; Asian shares decline

Read more about Sensex, Nifty pare gains; Asian shares decline on Business Standard. The benchmark indices pared gains in mid-morning trade. The Nifty held above the 15,000 mark. IT shares witnessed some bit of value buying. At 11:24 IST, the barometer index, the S&P BSE Sensex, was up 282.24 points or 0.56% to 50,687.56. The Nifty
Saudi Arabia United States Saudi Arabian Mishra Dhatu Nigam Larsen Toubro Infotech Joe Biden

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science